Clinical trial

A Study to Compare Human Thrombin Against Bovine Thrombin in Its Ability to Stop…

NCT00196534 · Ethicon, Inc., Industry · Completed

Key facts

NCT number NCT00196534
Title A Study to Compare Human Thrombin Against Bovine Thrombin in Its Ability to Stop Bleeding After Surgery
Official title A Comparative Evaluation of Human Thrombin Versus Bovine Thrombin in Achieving Hemostasis in Patients Undergoing Cardiovascular, Neurologic (Spine) and General Surgery Procedures.
Lead sponsor Ethicon, Inc., Industry
Collaborators OMRIX Biopharmaceuticals Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Cardiovascular, Neurologic (Spine), and General Surgery
Intervention type Drug
Interventions Human Thrombin, Bovine Thrombin
Enrollment 304
Start date Nov 1, 2004
Completion Jul 1, 2006
First posted Sep 20, 2005
Last update posted Aug 28, 2007
Countries United States

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies